Soleus Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.05M | Sell |
254,689
-214,811
| -46% | -$5.94M | 0.47% | 47 |
|
|
2025
Q1 | $10.4M | Buy |
+469,500
| New | +$10.4M | 0.75% | 34 |
|
|
2024
Q4 | – | Sell |
-302,500
| Closed | -$7.56M | – | 96 |
|
|
2024
Q3 | $7.56M | Buy |
302,500
+102,500
| +51% | +$2.56M | 0.59% | 45 |
|
|
2024
Q2 | $3.73M | Buy |
+200,000
| New | +$3.73M | 0.33% | 68 |
|
|
2023
Q4 | – | Sell |
-157,349
| Closed | -$2.73M | – | 91 |
|
|
2023
Q3 | $2.73M | Sell |
157,349
-362,291
| -70% | -$6.29M | 0.25% | 64 |
|
|
2023
Q2 | $7.32M | Buy |
+519,640
| New | +$7.32M | 0.81% | 39 |
|